These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36080216)

  • 1.
    Cruz-Nova P; Ocampo-García B; Carrión-Estrada DA; Briseño-Diaz P; Ferro-Flores G; Jiménez-Mancilla N; Correa-Basurto J; Bello M; Vega-Loyo L; Thompson-Bonilla MDR; Hernández-Rivas R; Vargas M
    Molecules; 2022 Aug; 27(17):. PubMed ID: 36080216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The small organic molecule C19 binds and strengthens the KRAS4b-PDEδ complex and inhibits growth of colorectal cancer cells in vitro and in vivo.
    Cruz-Nova P; Schnoor M; Correa-Basurto J; Bello M; Briseño-Diaz P; Rojo-Domínguez A; Ortiz-Mendoza CM; Guerrero-Aguirre J; García-Vázquez FJ; Hernández-Rivas R; Thompson-Bonilla MDR; Vargas M
    BMC Cancer; 2018 Nov; 18(1):1056. PubMed ID: 30382908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer.
    Casique-Aguirre D; Briseño-Díaz P; García-Gutiérrez P; la Rosa CHG; Quintero-Barceinas RS; Rojo-Domínguez A; Vergara I; Medina LA; Correa-Basurto J; Bello M; Hernández-Rivas R; Del RocioThompson-Bonilla M; Vargas M
    BMC Cancer; 2018 Dec; 18(1):1299. PubMed ID: 30594165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineoplastic effect of compounds C14 and P8 on TNBC and radioresistant TNBC cells by stabilizing the K-Ras4B
    Carrión-Estrada DA; Aguilar-Rojas A; Huerta-Yepez S; Montecillo-Aguado M; Bello M; Rojo-Domínguez A; Arechaga-Ocampo E; Briseño-Díaz P; Meraz-Ríos MA; Thompson-Bonilla MDR; Hernández-Rivas R; Vargas M
    Front Oncol; 2024; 14():1341766. PubMed ID: 38571493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.
    Mazhab-Jafari MT; Marshall CB; Smith MJ; Gasmi-Seabrook GM; Stathopulos PB; Inagaki F; Kay LE; Neel BG; Ikura M
    Proc Natl Acad Sci U S A; 2015 May; 112(21):6625-30. PubMed ID: 25941399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of the Signaling Protein K-Ras4B from Lipid Membranes Induced by a Molecular Tweezer.
    Li L; Erwin N; Möbitz S; Niemeyer F; Schrader T; Winter RHA
    Chemistry; 2019 Jul; 25(42):9827-9833. PubMed ID: 31141233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flexible-body motions of calmodulin and the farnesylated hypervariable region yield a high-affinity interaction enabling K-Ras4B membrane extraction.
    Jang H; Banerjee A; Chavan T; Gaponenko V; Nussinov R
    J Biol Chem; 2017 Jul; 292(30):12544-12559. PubMed ID: 28623230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K-Ras4B/calmodulin/PI3Kα: A promising new adenocarcinoma-specific drug target?
    Nussinov R; Muratcioglu S; Tsai CJ; Jang H; Gursoy A; Keskin O
    Expert Opin Ther Targets; 2016 Jul; 20(7):831-42. PubMed ID: 26873344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hypervariable Region of K-Ras4B Governs Molecular Recognition and Function.
    Abdelkarim H; Banerjee A; Grudzien P; Leschinsky N; Abushaer M; Gaponenko V
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-sectional study examining the expression of splice variants K-RAS4A and K-RAS4B in advanced non-small-cell lung cancer patients.
    Aran V; Masson Domingues P; Carvalho de Macedo F; Moreira de Sousa CA; Caldas Montella T; de Souza Accioly MT; Ferreira CG
    Lung Cancer; 2018 Feb; 116():7-14. PubMed ID: 29413054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Arylidene(chromenyl-methylene)-thiazolidinediones: Potential New Agents against Mutant Oncoproteins K-Ras, N-Ras and B-Raf in Colorectal Cancer and Melanoma.
    Nastasă C; Tamaian R; Oniga O; Tiperciuc B
    Medicina (Kaunas); 2019 Mar; 55(4):. PubMed ID: 30935124
    [No Abstract]   [Full Text] [Related]  

  • 12. K-Ras4A splice variant is widely expressed in cancer and uses a hybrid membrane-targeting motif.
    Tsai FD; Lopes MS; Zhou M; Court H; Ponce O; Fiordalisi JJ; Gierut JJ; Cox AD; Haigis KM; Philips MR
    Proc Natl Acad Sci U S A; 2015 Jan; 112(3):779-84. PubMed ID: 25561545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High affinity for farnesyltransferase and alternative prenylation contribute individually to K-Ras4B resistance to farnesyltransferase inhibitors.
    Fiordalisi JJ; Johnson RL; Weinbaum CA; Sakabe K; Chen Z; Casey PJ; Cox AD
    J Biol Chem; 2003 Oct; 278(43):41718-27. PubMed ID: 12882980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight into the mechanism of allosteric activation of PI3Kα by oncoprotein K-Ras4B.
    Li X; Dai J; Ni D; He X; Zhang H; Zhang J; Fu Q; Liu Y; Lu S
    Int J Biol Macromol; 2020 Feb; 144():643-655. PubMed ID: 31816384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hypervariable region of K-Ras4B is responsible for its specific interactions with calmodulin.
    Abraham SJ; Nolet RP; Calvert RJ; Anderson LM; Gaponenko V
    Biochemistry; 2009 Aug; 48(32):7575-83. PubMed ID: 19583261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of K-Ras4B-plasma membrane association with a membrane microdomain-targeting peptide.
    Li FY; Zhang ZF; Voss S; Wu YW; Zhao YF; Li YM; Chen YX
    Chem Sci; 2019 Dec; 11(3):826-832. PubMed ID: 34123058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer.
    Vakana E; Pratt S; Blosser W; Dowless M; Simpson N; Yuan XJ; Jaken S; Manro J; Stephens J; Zhang Y; Huber L; Peng SB; Stancato LF
    Oncotarget; 2017 Feb; 8(6):9251-9266. PubMed ID: 27999210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation Weakens but Does Not Inhibit Membrane Binding and Clustering of K-Ras4B.
    Zhang SY; Sperlich B; Li FY; Al-Ayoubi S; Chen HX; Zhao YF; Li YM; Weise K; Winter R; Chen YX
    ACS Chem Biol; 2017 Jun; 12(6):1703-1710. PubMed ID: 28448716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumorigenesis of K-ras mutation in human endometrial carcinoma via upregulation of estrogen receptor.
    Tu Z; Gui L; Wang J; Li X; Sun P; Wei L
    Gynecol Oncol; 2006 May; 101(2):274-9. PubMed ID: 16303170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markov State Models and Molecular Dynamics Simulations Reveal the Conformational Transition of the Intrinsically Disordered Hypervariable Region of K-Ras4B to the Ordered Conformation.
    Zhang H; Ni D; Fan J; Li M; Zhang J; Hua C; Nussinov R; Lu S
    J Chem Inf Model; 2022 Sep; 62(17):4222-4231. PubMed ID: 35994329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.